Inari Medical Announces Three New Data Sets to be Presented During Late-Breaking Clinical Trial Sessions at the 2022 TCT and VEINS Conferences

01.09.2022 - IRVINE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) - Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced ...

Related Keywords

Washington ,United States ,Steven Abramowitz Medstar Heath ,David Dexter Sentara ,Las Vegas ,Thomas Tu ,Inari Medical Inc , ,David Dexter ,Sentara Vascular Specialists ,Steven Abramowitz ,Medstar Heath ,Late Breaking Clinical Trials ,Chief Medical ,Inari Medical ,